|
|
|
|
LEADER |
02287nam a22004335i 4500 |
001 |
978-1-4614-1662-3 |
003 |
DE-He213 |
005 |
20150726161814.0 |
007 |
cr nn 008mamaa |
008 |
111012s2012 xxu| s |||| 0|eng d |
020 |
|
|
|a 9781461416623
|9 978-1-4614-1662-3
|
024 |
7 |
|
|a 10.1007/978-1-4614-1662-3
|2 doi
|
040 |
|
|
|d GrThAP
|
050 |
|
4 |
|a R-RZ
|
072 |
|
7 |
|a MBGR
|2 bicssc
|
072 |
|
7 |
|a MED000000
|2 bisacsh
|
082 |
0 |
4 |
|a 610
|2 23
|
100 |
1 |
|
|a Turner, J. Rick.
|e author.
|
245 |
1 |
0 |
|a Key Statistical Concepts in Clinical Trials for Pharma
|h [electronic resource] /
|c by J. Rick Turner.
|
264 |
|
1 |
|a New York, NY :
|b Springer New York,
|c 2012.
|
300 |
|
|
|a IX, 61 p. 1 illus.
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a text file
|b PDF
|2 rda
|
490 |
1 |
|
|a SpringerBriefs in Pharmaceutical Science & Drug Development,
|x 1864-8118
|
520 |
|
|
|a This Brief discusses key statistical concepts that facilitate the inferential analysis of data collected from a group of individuals participating in a pharmaceutical clinical trial, the estimation of their clinical significance in the general population of individuals likely to be prescribed the drug if approved, and the related decision-making that occurs at both the public health level (by regulatory agencies when deciding whether or not to approve a new drug for marketing) and the individual patient level (by physicians and their patients when deciding whether or not the patient should be prescribed a drug that is on the market). These concepts include drug safety and efficacy, statistical significance, clinical significance, and benefit-risk balance.
|
650 |
|
0 |
|a Medicine.
|
650 |
|
0 |
|a Pharmaceutical technology.
|
650 |
1 |
4 |
|a Biomedicine.
|
650 |
2 |
4 |
|a Biomedicine general.
|
650 |
2 |
4 |
|a Pharmaceutical Sciences/Technology.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|
776 |
0 |
8 |
|i Printed edition:
|z 9781461416616
|
830 |
|
0 |
|a SpringerBriefs in Pharmaceutical Science & Drug Development,
|x 1864-8118
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1007/978-1-4614-1662-3
|z Full Text via HEAL-Link
|
912 |
|
|
|a ZDB-2-SBL
|
950 |
|
|
|a Biomedical and Life Sciences (Springer-11642)
|